Biopharma CEOs Weigh In On Working With Wall St. During Pandemic Pandemonium
Source: Life Science Leader
Rob Wright, chief editor of Life Science Leader, conducted a roundtable virtually with three CEOs of publicly traded biopharmaceutical companies (view full video here). In this section, three CEOs discuss working with Wall St. and keeping investors informed during pandemic pandemonium.
Appearing in this video (in order) are:
- Bill Newell, J.D., CEO, Sutro Biopharma
- Mike Sherman, CEO, Chimerix
- Karen Zaderej, CEO, AxoGen
This website uses cookies to ensure you get the best experience on our website. Learn more